• This record comes from PubMed

Combined efficacy of Cinnamomum zeylanicum and doxorubicin against leukemia through regulation of TRAIL and NF-kappa B pathways in rat model

. 2022 Jul ; 49 (7) : 6495-6507. [epub] 20220517

Language English Country Netherlands Media print-electronic

Document type Journal Article

Grant support
URF Quaid-i-Azam University

Links

PubMed 35579734
DOI 10.1007/s11033-022-07478-y
PII: 10.1007/s11033-022-07478-y
Knihovny.cz E-resources

BACKGROUND: Recent discoveries in cancer therapeutics have proven combination therapies more effective than individual drugs. This study describes the efficacy of the combination of Cinnamomum zeylanicum and doxorubicin against benzene-induced leukemia. METHODS AND RESULTS: Brine shrimp assay was used to assess the cytotoxicity of C. zeylanicum, doxorubicin and their combination. After AML induction in Sprague Dawley rats, the same drugs were given to rat groups. Changes in organ weight, haematological profile, and hepatic enzymes were determined. Real-time PCR was used to elucidate the effect on the expression of STMN1, GAPDH, P53 and various TRAIL and NF-kappaB components. C. zeylanicum reduced the cytotoxicity of doxorubicin. The combination treatment showed better anti-leukemic results than any of the individual drugs as evident from STMN1 expression (p < 0.001). It was particularly effective in reducing total white blood cell counts and recovering lymphocytes, monocytes and eosinophils along with hepatic enzymes ALT and AST (p < 0.001). All doses recovered relative organ weights and improved blood parameters. The combination therapy was particularly effective in inducing apoptosis, inhibition of proliferation marker GAPDH (p < 0.001) and NF-kappaB pathway components Rel-A (p < 0.001) and Rel-B (p < 0.01). Expressions of TRAIL components c-FLIP (p < 0.001), TRAIL ligand (p < 0.001) and caspase 8 (p < 0.01) were also altered. CONCLUSION: Cinnamomum zeylanicum in combination with doxorubicin helps to counter benzene-induced cellular and hepatic toxicity and improves haematological profile. The anti-leukemic effects are potentially due to inhibition of GAPDH and NF-kappa B pathway, and through regulation of TRAIL pathway. Our data suggests the use of C. zeylanicum with doxorubicin to improve anti-leukemic therapeutic regimes.

See more in PubMed

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin D, Piñeros M, Znaor A, Bray F (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144(8):1941–1953 PubMed

Dean A, Ferguson J, Marvanr E (2003) Acute leukaemia presenting as oral ulceration to a dental emergency service. Aust Dent J 48(3):195–197 PubMed

Lowenberg B, Downing JR, Burnett A (1999) Acute myeloid leukemia. N Engl J Med 341(14):1051–1062 PubMed

Shipley JL, Butera JN (2009) Acute myelogenous leukemia. Exp Hematol 37(6):649–658 PubMed

Karaulov AV, Mikhaylova IV, Smolyagin AI, Boev VM, Kalogeraki A, Tsatsakis AM, EnginA B (2017) The immunotoxicological pattern of subchronic and chronic benzene exposure in rats. Toxicol Lett 275:1–5 PubMed

Aksoy M (1989) Hematotoxicity and carcinogenicity of benzene. Environ Health Perspect 82:193–197 PubMed PMC

Atkinson TJ (2009) A review of the role of benzene metabolites and mechanisms in malignant transformation: summative evidence for a lack of research in nonmyelogenous cancer types. Int J Hyg Environ Health 212(1):1–10 PubMed

Ashley N, Poulton J (2009) Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs. Biochem Biophys Res Commun 378(3):450–455 PubMed

Carvalho C, Santos RX, CardosoS CS, Oliveira PJ, Santos MS, Moreira PI (2009) Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16(25):3267–3285 PubMed

Marongiu B, Piras A, Porcedda S, Tuveri E, Sanjust E, Meli M, Sollai F, Zucca P, Rescigno A (2007) Supercritical CO PubMed

Ranasinghe P, Pigera S, Premakumara GS, Galappaththy P, Constantine GR, Katulanda P (2013) Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): a review. BMC Complement Altern Med 13(1):275 PubMed PMC

Assadollahi V, Parivar K, Roudbari NH, Khalatbary AR, Motamedi M, Ezatpour B, Dashti GR (2013) The effect of aqueous cinnamon extract on the apoptotic process in acute myeloid leukemia HL-60 cells. Adv Biomed Res. https://doi.org/10.4103/2277-9175.108001 PubMed DOI PMC

Golla K, Cherukuvada B, Ahmed F, Kondapi AK (2012) Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats. PLoS ONE 7(12):e51960 PubMed PMC

Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y (2003) Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract 62(3):139–148 PubMed

Hong JW, Yang GE, Kim YB, Eom SH, Lew JH, Kang H (2012) Anti-inflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced models. BMC Complement Altern Med 12(1):237 PubMed PMC

Chomczynski P (2010) Reagents and methods for isolation of purified RNA. Google Patents

Ni PZ, He JZ, Wu ZY, Ji X, Chen LQ, Xu XE, Liao LD, Wu JY, Li EM, Xu LY (2017) Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma. Oncol Rep 38(6):3608–3618 PubMed

Serachi FdO, Marie SKN, Oba-Shinjo SM (2017) Relevant coexpression of STMN1, MELK and FOXM1 in glioblastoma and review of the impact of STMN1 in cancer biology. Med Express. https://doi.org/10.5935/MedicalExpress.2017.05.07 DOI

Weinberg RA (2013) The biology of cancer. Garland Science, New York

Collins J, Ireland B, Buckley C, Shepperly D (2003) Lymphohaematopoeitic cancer mortality among workers with benzene exposure. Occup Environ Med 60(9):676–679 PubMed PMC

Carney D, Westerman D, Tam C, Milner A, Prince H, Kenealy M, Wolf M, Januszewicz E, Ritchie D, Came N (2010) Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. Leukemia 24(12):2056 PubMed

Chatterjee K, Zhang J, Honbo N, Karliner JS (2010) Doxorubicin cardiomyopathy. Cardiology 115(2):155–162 PubMed

Ka H, Park HJ, Jung HJ, Choi JW, Cho KS, Ha J, Lee KT (2003) Cinnamaldehyde induces apoptosis by ROS-mediated mitochondrial permeability transition in human promyelocytic leukemia HL-60 cells. Cancer Lett 196(2):143–152 PubMed

Xi J, Yun M, Lee D, Park MN, Kim EO, Sohn EJ, Kwon BM (2015) Cinnamaldehyde derivative (CB-PIC) sensitizes chemo-resistant cancer cells to drug-induced apoptosis via suppression of MDR1 and its upstream STAT3 and AKT signalling. Cell Physiol Biochem 35(5):1821–1830

Aggarwal BB, Shishodia S (2004) Suppression of the nuclear factor-kB activation pathway by spice-derived phytochemicals. Ann NY Acad Sci 1030:434–441 PubMed

Islam SS, Aboussekhra A (2019) Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway. J Exp Clin Cancer Res 38(1):382 PubMed PMC

Sandamali JAN, Hewawasam RP, Jayatilaka KAPW, Mudduwa LKB (2018) Protective effect of cinnamomum zeylanicum bark extract againstdoxorubicin induced cardiotoxicity: a preliminary study. Int J Med Health Sci 12(7):2018

Larasati YA, Meiyanto E (2018) Revealing the potency of cinnamon as an anti-cancer and chemopreventive agent. Indonesian J Cancer Chemoprev 9(1):47–62

Handschuh L, Kaźmierczak M, Milewski MC, Góralski M, Łuczak M, Wojtaszewska M, Uszczyńska-Ratajczak B, Lewandowski K, Komarnicki M, Figlerowicz M (2018) Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and-M2 through boutique microarrays, real-time PCR and droplet digital PCR. Int J Oncol 52(3):656–678 PubMed

Kazemi F, Najafabadi TA, Araabi BN (2016) Automatic recognition of acute myelogenous leukemia in blood microscopic images using k-means clustering and support vector machine. J Med Signals Sens 6(3):183 PubMed PMC

Shahab F, Raziq F (2014) Clinical presentations of acute leukemia. J Coll Physicians Surg Pak 24(7):472–476 PubMed

Dorri M, Hashemitabar S, Hosseinzadeh H (2018) Cinnamon (Cinnamomum zeylanicum) as an antidote or a protective agent against natural or chemical toxicities: a review. Drug Chem Toxicol 41(3):338–351 PubMed

Khafaji SS (2018) Study the effect of ceylon cinnamon (Cinnamomum zeylanicum) powder on some physiological parameters in broiler chicks. J Glob Pharma Technol 10(7):236–242

Morgan AM, El-Ballal SS, El-Bialy BE, El-Borai NB (2014) Studies on the potential protective effect of cinnamon against bisphenol A-and octylphenol-induced oxidative stress in male albino rats. Toxicol Rep 1:92–101 PubMed PMC

Ghonim A, Abdeen A, El-Shawarby R, Abdel-Aleem N, El-Shewy E, Abdo M, Abdelhiee E (2017) Protective effect of cinnamon against cadmium-induced hepatorenal oxidative damage in rats. Int J Pharmacol Toxicol 5(1):17–22

Shen Y, Shen H, Shi C, Ong C (1996) Benzene metabolites enhance reactive oxygen species generation in HL60 human leukemia cells. Hum Exp Toxicol 15(5):422–427 PubMed

Dere E, Ari F (2009) Effect of benzene on liver functions in rats (Rattus norvegicus). Environ Monit Assess 154(1–4):23–27 PubMed

Sandamali JAN, Hewawasam RP, Jayatilaka KA, Mudduwa LKB (2021) Cinnamomum zeylanicum Blume (Ceylon cinnamon) bark extract attenuates doxorubicin induced cardiotoxicity in Wistar rats. Saudi Pharma J 29(8):820–832

Guo C, Liu S, Sun MZ (2013) Novel insight into the role of GAPDH playing in tumor. Clin Transl Oncol 15(3):167–172 PubMed

Jones W, Bianchi K (2015) Aerobic glycolysis: beyond proliferation. Front Immunol 6:227 PubMed PMC

Boley SE, Anderson EE, French JE, Donehower LA, Walker DB, Recio L (2000) Loss of p53 in benzene-induced thymic lymphomas in p53+/− mice: evidence of chromosomal recombination. Cancer Res 60(11):2831–2835 PubMed

Greenblatt M (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855–4878 PubMed

Tsang W, Chau SP, Kong S, Fung K, Kwok T (2003) Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci 73(16):2047–2058 PubMed

Yang F, Chen H, Liu Y, Yin K, Wang Y, Li X, Wang G, Wang S, Tan X, Xu C (2013) Doxorubicin caused apoptosis of mesenchymal stem cells via p38, JNK and p53 pathway. Cell Physiol Biochem 32(4):1072–1082 PubMed

Schoene NW, Kelly MA, Polansky MM, Anderson RA (2005) Water-soluble polymeric polyphenols from cinnamon inhibit proliferation and alter cell cycle distribution patterns of hematologic tumor cell lines. Cancer Lett 230(1):134–140 PubMed

Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms intermediacy of H PubMed

Kelly MM, Hoel BD, Voelkel-Johnson C (2002) Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression. Cancer Biol Ther 1(5):520–527 PubMed

Kang J, Bu J, Hao Y, Chen F (2005) Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP. Prostate Cancer Prostatic Dis 8(3):274–279 PubMed

Anees M, Horak P, El-Gazzar A, Susani M, Heinze G, Perco P, Loda M, Lis R, Krainer M, Oh WK (2011) Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression. Cancer 117(6):1172–1182 PubMed

Huang TC, Fu HY, Ho CT, Tan D, Huang YT, Pan MH (2007) Induction of apoptosis by cinnamaldehyde from indigenous cinnamon Cinnamomum osmophloeum Kaneh through reactive oxygen species production, glutathione depletion, and caspase activation in human leukemia K562 cells. Food Chem 103(2):434–443

Wu SJ, Ng LT, Lin CC (2005) Cinnamaldehyde-induced apoptosis in human PLC/PRF/5 cells through activation of the proapoptotic Bcl-2 family proteins and MAPK pathway. Life Sci 77(8):938–951 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...